At a glance
ClinicalIndex Comparison RecordN/ACompleted· 124 enrolled
Drug / intervention
per interventionprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Discovery of New Circulating Biomarkers of Coronary Atherosclerosis Using Differential Proteomics: the BIOmarkers of CORonary Events (BIOCORE) Study
In Brief
An observational study evaluating per intervention for Coronary Artery Disease and 3 related conditions. Completed, enrolled 124 participants across 1 site.
Detailed Summary
The study hypothesis is that differential proteomic techniques can be used to discover new circulating biomarkers of coronary atherosclerosis in the blood of patients suffering from coronary artery disease (either stable or unstable) who will be compared to a group of patients without coronary artery disease
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesFrance
Timeline
N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedFeb 2007
Enrollment StartMar 2007
Primary CompletionJul 2009
Study CompletionNov 2009
TodayJul 2026
First PostedFeb 2, 2007
Enrollment StartMar 1, 2007
Primary CompletionJul 1, 2009
Study CompletionNov 1, 2009
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 19.4 years ago
Interventions
per interventionprocedure
per intervention